3327 Live Notices for Germany Pharmaceutical Products Tenders
Showing 1 to 20
Curriculum Of Medicine
22 Nov 2024
05 Dec 2024Rv Qe2Dvr9090 -Blood Products-Blood Coagulation Factors I, Xiii, Rabies And Tetanus Immunoglobulin
Rv First Aid And Wound Care Material In 3 Lots: 1St Lot: First Aid And Wound Care Material 2Nd Lot: Disinfectant 3Rd Lot: Disposable Protective Gloves
Conception And Realization Of A Vr Solution
Rv First Aid And Wound Care Material In 3 Lots: 1St Lot: First Aid And Wound Care Material 2Nd Lot: Disinfectant 3Rd Lot: Disposable Protective Gloves
Conclusion Of A Non-Exclusive Drug Discount Agreement Pursuant To Section 130A Paragraph 8 Of The Social Code Book V By Means Of An Open-House Model For The Active Ingredient Ambrisentan (Atc Code According To Who: C02Kx02)
Conclusion Of A Non-Exclusive Drug Discount Agreement Pursuant To Section 130A Paragraph 8 Of The Social Code Book V By Means Of An Open-House Model For The Active Ingredient Ambrisentan (Atc Code According To Who: C02Kx02)
Clinical Chemistry & Immunology Lvr Clinics
Conclusion Of A Non-Exclusive Drug Discount Agreement Pursuant To Section 130A Paragraph 8 Of The Social Code Book V By Means Of An Open-House Model For The Active Ingredient Ambrisentan (Atc Code According To Who: C02Kx02)
Conclusion Of A Non-Exclusive Drug Discount Agreement Pursuant To Section 130A Paragraph 8 Of The Social Code Book V By Means Of An Open-House Model For The Active Ingredient Ambrisentan (Atc Code According To Who: C02Kx02)
Conclusion Of A Non-Exclusive Drug Discount Agreement Pursuant To Section 130A Paragraph 8 Of The Social Code Book V By Means Of An Open-House Model For The Active Ingredient Ambrisentan (Atc Code According To Who: C02Kx02)
Conclusion Of A Non-Exclusive Drug Discount Agreement Pursuant To Section 130A Paragraph 8 Of The Social Code Book V By Means Of An Open-House Model For The Active Ingredient Ambrisentan (Atc Code According To Who: C02Kx02)
Conclusion Of A Non-Exclusive Drug Discount Agreement Pursuant To Section 130A Paragraph 8 Of The Social Code Book V By Means Of An Open-House Model For The Active Ingredient Ambrisentan (Atc Code According To Who: C02Kx02)
Conclusion Of A Non-Exclusive Drug Discount Agreement Pursuant To Section 130A Paragraph 8 Of The Social Code Book V By Means Of An Open-House Model For The Active Ingredient Ambrisentan (Atc Code According To Who: C02Kx02)
Conclusion Of A Non-Exclusive Drug Discount Agreement Pursuant To Section 130A Paragraph 8 Of The Social Code Book V By Means Of An Open-House Model For The Active Ingredient Ambrisentan (Atc Code According To Who: C02Kx02)
Conclusion Of A Non-Exclusive Drug Discount Agreement Pursuant To Section 130A Paragraph 8 Of The Social Code Book V By Means Of An Open-House Model For The Active Ingredient Ambrisentan (Atc Code According To Who: C02Kx02)
Conclusion Of A Non-Exclusive Drug Discount Agreement Pursuant To Section 130A Paragraph 8 Of The Social Code Book V By Means Of An Open-House Model For The Active Ingredient Ambrisentan (Atc Code According To Who: C02Kx02)
Conclusion Of A Non-Exclusive Drug Discount Agreement Pursuant To Section 130A Paragraph 8 Of The Social Code Book V By Means Of An Open-House Model For The Active Ingredient Ambrisentan (Atc Code According To Who: C02Kx02)
Conclusion Of A Non-Exclusive Drug Discount Agreement Pursuant To Section 130A Paragraph 8 Of The Social Code Book V By Means Of An Open-House Model For The Active Ingredient Ambrisentan (Atc Code According To Who: C02Kx02)
Conclusion Of A Non-Exclusive Drug Discount Agreement Pursuant To Section 130A Paragraph 8 Of The Social Code Book V By Means Of An Open-House Model For The Active Ingredient Ambrisentan (Atc Code According To Who: C02Kx02)
Tenders by Country